Protein Microarrays: Valuable Tools for Ocular Diseases Research
-
Published:2020-08-05
Issue:27
Volume:27
Page:4549-4566
-
ISSN:0929-8673
-
Container-title:Current Medicinal Chemistry
-
language:en
-
Short-container-title:CMC
Author:
Garranzo-Asensio María1ORCID, Montero-Calle Ana2ORCID, Solís-Fernández Guillermo2ORCID, Barderas Rodrigo2ORCID, Guzman-Aranguez Ana1ORCID
Affiliation:
1. Department of Biochemistry and Molecular Biology, Faculty of Optics and Optometry, Universidad Complutense de Madrid, C/Arcos de Jalon 118, Madrid 28037, Spain 2. Functional Proteomics Unit, Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
Abstract
:
The eye is a complex organ comprised of several compartments with exclusive and specialized
properties that reflect their diverse functions. Although the prevalence of eye pathologies is
increasing, mainly because of its correlation with aging and of generalized lifestyle changes, the
pathogenic molecular mechanisms of many common ocular diseases remain poorly understood.
Therefore, there is an unmet need to delve into the pathogenesis, diagnosis, and treatment
of eye diseases to preserve ocular health and reduce the incidence of visual impairment or blindness.
Proteomics analysis stands as a valuable tool for deciphering protein profiles related to specific ocular
conditions. In turn, such profiles can lead to real breakthroughs in the fields of ocular science and
ophthalmology. Among proteomics techniques, protein microarray technology stands out by providing
expanded information using very small volumes of samples.
:
In this review, we present a brief summary of the main types of protein microarrays and their application
for the identification of protein changes in chronic ocular diseases such as dry eye, glaucoma,
age-related macular degeneration, or diabetic retinopathy. The validation of these specific protein
alterations could provide new biomarkers, disclose eye diseases pathways, and help in the diagnosis
and development of novel therapies for eye pathologies.
Funder
Spanish Ministry of Economy and Competitivity Europeo de Desarrollo Regional-FEDER
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference125 articles.
1. Akpek, E.K.; Smith, R.A. Overview of age-related ocular conditions. Am, J. Manag. Care. 2013,19(5) (Suppl.),S67-S75. PMID: 23725498 2. Klein,R.; Klein, B.E. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest. Ophthalmol. Vis. Sci. 2013,54(14),ORSF5-ORSF13. http://dx.doi.org/10.1167/iovs.13-12789 PMID: 24335069 3. Ahmad, M.T.; Zhang,P.; Dufresne,C.; Ferrucci,L.; Semba, R.D. The human eye proteome project: updates on an emerging proteome. Proteomics. 2018,18(5-6),e1700394. http://dx.doi.org/10.1002/pmic.201700394 PMID: 29356342 4. Azkargorta,M.; Soria,J.; Acera,A.; Iloro,I.; Elortza, F. Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice, J. Proteomics. 2017,150,359-367. http://dx.doi.org/10.1016/j.jprot.2016.05.006 PMID: 27184738 5. Rocha, A.S.; Santos, F.M.; Monteiro, J.P.; Castro-de-Sousa, J.P.; Queiroz, J.A.; Tomaz, C.T.; Passarinha, L.A. Trends in proteomic analysis of human vitreous humor samples. Elec-trophoresis. 2014,35(17),2495-2508. http://dx.doi.org/10.1002/elps.201400049 PMID: 24825767
|
|